Amgen AFP will reduce head count for all Amgen including Onyx. More so within Amgen but it will hit your departments as well to a lesser extent. KI will be expanding but they will be shedding those such as SC and will put in place people TH likes. Amgen Can't control onyx directly but can through choosing who is in charge aka pawns for TH. Amgen needs you separate to run therapeutic onc without being under the CIA. So the only control TH and amgen will have is control of leadership and employees in your org. If you don't fit the mold they will can you. Then expand with an army of lemmings that's Amgen can control. So yes Amgen is expanding onyx but it's not like you will have full control as you think.